To investigate the functional importance of PA2G4 in MYCN-driven neuroblastoma in vivo, we utilized the Th-MYCN transgenic mouse model, in which the human MYCN gene is expressed under the control of the tyrosine hydroxylase promoter. The gene discussed is PA2G4; the disease is neuroblastoma.